Cargando...
Resistance to HER2-targeted therapies: a potential role for FOXM1
Despite the tremendous efficacy of trastuzumab against HER2-overexpressing metastatic breast cancers, a significant fraction of women demonstrate progressive disease during treatment. Multiple mechanisms have been proposed to mediate trastuzumab resistance. In this mini-review, we discuss the eviden...
Guardado en:
| Publicado en: | Breast Cancer Manag |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4294221/ https://ncbi.nlm.nih.gov/pubmed/25598845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/bmt.14.33 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|